Healthify is banking on the rise of GLP-1 weight-loss drugs in India, integrating them with lifestyle coaching. The firm ...

Sodium-glucose cotransporter-2 inhibitors (SGLT2i), or gliflozins, are medications used in the treatment of type 2 diabetes ...

This inexpensive generic significantly reduced knee pain in a small trial of people who are overweight or have obesity.

Opioids, antidepressants, and some NSAIDs increase the risk of constipation. Find out which ones do and what helps bowel ...

President Donald Trump is under pressure to decide how widely available anti-obesity drugs should be and whether Medicare ...

A single intravitreal injection of UBX1325 (foselutoclax) was shown to be safe in patients with diabetic macular edema. The ...

New Delhi: A common diabetes drug can help reduce pain in people with knee osteoarthritis (OA) and obesity, as well as delay ...

A common diabetes drug can reduce the pain of people with knee osteoarthritis and overweight or obesity, possibly delaying the need for knee replacements, Monash University-led research has found.

A common diabetes drug can reduce the pain of people with knee osteoarthritis and overweight or obesity, possibly delaying the need for knee replacements, Monash University-led research has found.

The ‘4S’ Pathway was designed to guide shifting needs in older adults with diabetes who are struggling with diabetes ...

Experts say 85% price drop in empagliflozin expected to boost SGLT2 usage; SGLT-2 class of drugs account for 25-30% of all diabetes prescriptions ...

Type 5 Diabetes, has now come under the spotlight after official recognition by the International Diabetes Federation. This ...